These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 28032631)

  • 21. Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosis.
    Udell JA; Steg PG; Scirica BM; Eagle KA; Ohman EM; Goto S; Alsheikh-Ali AA; Porath A; Corbalan R; Umez-Eronini AA; Hoffman EB; Wilson PW; Bhatt DL;
    Eur J Prev Cardiol; 2014 Dec; 21(12):1531-40. PubMed ID: 23918840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic Syndrome and C-reactive Protein are Associated With a Reduced Myocardial Mechano-energetic Efficiency.
    Cefalo CMA; Riccio A; Fiorentino TV; Succurro E; Miceli S; Mannino GC; Perticone M; Sciacqua A; Andreozzi F; Sesti G
    J Clin Endocrinol Metab; 2023 Oct; 108(11):e1264-e1271. PubMed ID: 37235788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pro-Neurotensin/Neuromedin N and Risk of Incident Metabolic Syndrome and Diabetes Mellitus in the REGARDS Cohort.
    Nicoli CD; Carson AP; Plante TB; Leann Long D; McClure LA; Schulte J; Cushman M
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3483-e3494. PubMed ID: 34013344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influences of hypertension and diabetes on normal age-related changes in left ventricular function as assessed by tissue Doppler echocardiography.
    Masugata H; Senda S; Goda F; Yamagami A; Okuyama H; Kohno T; Yukiiri K; Noma T; Hosomi N; Imai M; Kohno M
    Clin Exp Hypertens; 2009 Jul; 31(5):400-14. PubMed ID: 19811350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LV Mass as a Predictor of CVD Events in Older Adults With and Without Metabolic Syndrome and Diabetes.
    Hoang K; Zhao Y; Gardin JM; Carnethon M; Mukamal K; Yanez D; Wong ND
    JACC Cardiovasc Imaging; 2015 Sep; 8(9):1007-1015. PubMed ID: 26319502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertension and Organ Damage in Women.
    Muiesan ML; Paini A; Aggiusti C; Bertacchini F; Rosei CA; Salvetti M
    High Blood Press Cardiovasc Prev; 2018 Sep; 25(3):245-252. PubMed ID: 29943358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between serum magnesium concentration and metabolic syndrome, diabetes, hypertension and hyperuricaemia in knee osteoarthritis: a cross-sectional study in Hunan Province, China.
    Wang Y; Wei J; Zeng C; Yang T; Li H; Cui Y; Xie D; Xu B; Liu Z; Li J; Jiang S; Lei G
    BMJ Open; 2018 Sep; 8(9):e019159. PubMed ID: 30206073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-invasively estimated end-systolic elastance in patients with resistant hypertension and type 2 diabetes mellitus.
    Soender TK; De Backer T
    Heart Vessels; 2014 May; 29(3):375-83. PubMed ID: 23728366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome.
    Zanoli L; Di Pino A; Terranova V; Di Marca S; Pisano M; Di Quattro R; Ferrara V; Scicali R; Rabuazzo AM; Fatuzzo P; Castellino P; Piro S; Purrello F; Malatino L
    Nutr Metab Cardiovasc Dis; 2018 Dec; 28(12):1222-1229. PubMed ID: 30348591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Higher pulse pressure and risk for cardiovascular events in patients with essential hypertension: The Campania Salute Network.
    Mancusi C; Losi MA; Izzo R; Canciello G; Carlino MV; Albano G; De Luca N; Trimarco B; de Simone G
    Eur J Prev Cardiol; 2018 Feb; 25(3):235-243. PubMed ID: 29226693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of the myocardial performance index in a population with high prevalences of obesity, diabetes, and hypertension: the strong heart study.
    Mishra RK; Kizer JR; Palmieri V; Roman MJ; Galloway JM; Fabsitz RR; Lee ET; Best LG; Devereux RB
    Echocardiography; 2007 Apr; 24(4):340-7. PubMed ID: 17381641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood pressure control and components of the metabolic syndrome: the GOOD survey.
    Zidek W; Naditch-Brûlé L; Perlini S; Farsang C; Kjeldsen SE
    Cardiovasc Diabetol; 2009 Sep; 8():51. PubMed ID: 19754934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What Is the Effect of Metabolic Syndrome without Hypertension on Left Ventricular Hypertrophy?
    Al-Daydamony MM; El-Tahlawi M
    Echocardiography; 2016 Sep; 33(9):1284-9. PubMed ID: 27109543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic syndrome and abdominal fat are associated with inflammation, but not with clinical outcomes, in peritoneal dialysis patients.
    Huang JW; Yang CY; Wu HY; Liu KL; Su CT; Wu CK; Lee JK; Chiang CK; Cheng HT; Lien YC; Hung KY
    Cardiovasc Diabetol; 2013 Jun; 12():86. PubMed ID: 23758640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significant Association between Subclinical Left Cardiac Dysfunction and Liver Stiffness in Metabolic Syndrome Patients with Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease.
    Apostu A; Malita D; Arnautu SF; Tomescu MC; Gaiță D; Popescu A; Mare R; Gidea R; Arnautu DA
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837528
    [No Abstract]   [Full Text] [Related]  

  • 36. Aortic Root Dilatation Is Associated With Incident Cardiovascular Events in a Population of Treated Hypertensive Patients: The Campania Salute Network.
    Canciello G; Mancusi C; Losi MA; Izzo R; Trimarco B; de Simone G; De Luca N
    Am J Hypertens; 2018 Nov; 31(12):1317-1323. PubMed ID: 30099532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of exenatide on cardiac function, perfusion, and energetics in type 2 diabetic patients with cardiomyopathy: a randomized controlled trial against insulin glargine.
    Chen WJY; Diamant M; de Boer K; Harms HJ; Robbers LFHJ; van Rossum AC; Kramer MHH; Lammertsma AA; Knaapen P
    Cardiovasc Diabetol; 2017 May; 16(1):67. PubMed ID: 28526033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of Left Ventricular Hypertrophy in Treated Hypertensive Outpatients: The Campania Salute Network.
    Izzo R; Losi MA; Stabile E; Lönnebakken MT; Canciello G; Esposito G; Barbato E; De Luca N; Trimarco B; de Simone G
    Hypertension; 2017 Jan; 69(1):136-142. PubMed ID: 27895192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex Difference in the Association Between Metabolic Syndrome and Left Ventricular Diastolic Dysfunction.
    Kim HL; Kim MA; Oh S; Kim M; Park SM; Yoon HJ; Shin MS; Hong KS; Shin GJ; Shim WJ
    Metab Syndr Relat Disord; 2016 Dec; 14(10):507-512. PubMed ID: 27710153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease.
    Cioffi G; Viapiana O; Ognibeni F; Dalbeni A; Gatti D; Mazzone C; Faganello G; Di Lenarda A; Adami S; Rossini M
    J Am Soc Echocardiogr; 2016 Jul; 29(7):689-98. PubMed ID: 26922258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.